(Q28081347)

Nham Tran

series ordinal

2

1 reference

language of work or name

1 reference

2015

1 reference

published in

Biomarkers in Medicine

1 reference

volume

9

1 reference

issue

2

1 reference

page(s)

131-51

1 reference

Identification of novel genes coding for small expressed RNAs

cites work

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

An extensive class of small RNAs in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Biogenesis and the regulation of the maturation of miRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Detection of microRNAs in dried serum blots

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Exosomes: endosomal-derived vesicles shipping extracellular messages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Detection of microRNA expression in human peripheral blood microvesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Macrophage microvesicles induce macrophage differentiation and miR-223 transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Endothelial cells require miR-214 to secrete exosomes that suppress senescence and induce angiogenesis in human and mouse endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

MicroRNA transport: a new way in cell communication

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Export of microRNAs and microRNA-protective protein by mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

RNAi: nature abhors a double-strand

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Causes and consequences of microRNA dysregulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Impaired microRNA processing enhances cellular transformation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

miR-153 supports colorectal cancer progression via pleiotropic effects that enhance invasion and chemotherapeutic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

A new role for microRNAs, as ligands of Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Screening for Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Randomised controlled trial of faecal-occult-blood screening for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Randomised study of screening for colorectal cancer with faecal-occult-blood test

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Identification and evaluation of plasma microRNAs for early detection of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Prognostic implications of serum microRNA-21 in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Recurrence of early stage colon cancer predicted by expression pattern of circulating microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Computational analysis of mRNA expression profiles identifies microRNA-29a/c as predictor of colorectal cancer early recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

MiR-29c is downregulated in gastric carcinomas and regulates cell proliferation by targeting RCC2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Circulating microRNAs as novel minimally invasive biomarkers for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Analysis of serum genome-wide microRNAs for breast cancer detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Circulating microRNA profiles reflect the presence of breast tumours but not the profiles of microRNAs within the tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Discovery of novel human breast cancer microRNAs from deep sequencing data by analysis of pri-microRNA secondary structures

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

MicroRNA sequence and expression analysis in breast tumors by deep sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Serum microRNA-155 as a potential biomarker to track disease in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Zwitterionic polymer-coated immunobeads for blood-based cancer diagnostics.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Circulating microRNAs as specific biomarkers for breast cancer detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Serum circulating microRNA profiling for identification of potential breast cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Identification of circulating microRNA signatures for breast cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Circulating microRNAs in plasma as early detection markers for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Plasma microRNA panel for minimally invasive detection of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Prostate-specific antigen testing across the spectrum of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Early management of prostate cancer: how to respond to an elevated PSA?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Comparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Circulating microRNAs (miRNA) in serum of patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Changes in circulating microRNA levels associated with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

A panel of five circulating microRNAs as potential biomarkers for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Circulating microRNAs predict biochemical recurrence in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Plasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Detection of cancer with serum miRNAs on an oligonucleotide microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

MicroRNA signature predicts survival and relapse in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Clinical evaluation of microRNA expression profiling in non small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Decreased circulating miR-375: a potential biomarker for patients with non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

The identification of miR-375 as a potential biomarker in distal gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

MicroRNA expression profiles of whole blood in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Differential microRNAs expression in serum of patients with lung cancer, pulmonary tuberculosis, and pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Gastric cancer staging with dual energy spectral CT imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

The role of CT and staging laparoscopy in the staging of gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Circulating microRNAs in plasma of patients with gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Validation of circulating miRNA biomarkers for predicting lymph node metastasis in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Aberrant expression of miR-196a in gastric cancers and correlation with recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Determination of plasma microRNA for early detection of gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

MicroRNAs and bacterial infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

A critical evaluation of microRNA biomarkers in non-neoplastic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Haemolysis during sample preparation alters microRNA content of plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Red cell hemolysis during processing and storage

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

The microRNA spectrum in 12 body fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Once-Only Sigmoidoscopy in Colorectal Cancer Screening: Follow-up Findings of the Italian Randomized Controlled Trial--SCORE

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

Detection and Characterization of Placental MicroRNAs in Maternal Plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.14.102

21 January 2018

Identifiers

DOI

10.2217/BMM.14.102

1 reference

Consolidated OpenCitations Corpus – April 2017

release_svqvibcmzbfllczvmxffddz6kq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/svqvibcmzbfllczvmxffddz6kq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

25689901

1 reference

Consolidated OpenCitations Corpus – April 2017